Table of Content
Saudi Arabia In-Vitro Diagnostics Market Report - Table of Contents
- 1. INTRODUCTION
- 1.1 Study Assumptions and Market Defintiton
- 1.2 Scope of the Study
- 2. RESEARCH METHODOLOGY
- 3. EXECUTIVE SUMMARY
- 4. MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Increasing Burden of Infectious and Chronic Diseases
- 4.2.2 Increasing Use of Point of Care (POC) Diagnostics & Increasing Healthcare Expenditure
- 4.3 Market Restraints
- 4.3.1 Lack of Favorable Reimbursement Policies
- 4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
- 5. MARKET SEGMENTATION (Market Size by Value - USD million)
- 5.1 By Test Type
- 5.1.1 Clinical Chemistry
- 5.1.2 Molecular Diagnostics
- 5.1.3 Immuno Diagnostics
- 5.1.4 Haematology
- 5.1.5 Other Types
- 5.2 By Product
- 5.2.1 Instrument
- 5.2.2 Reagent
- 5.2.3 Other Product
- 5.3 By Usability
- 5.3.1 Disposable IVD Device
- 5.3.2 Reusable IVD Device
- 5.4 By Application
- 5.4.1 Infectious Disease
- 5.4.2 Diabetes
- 5.4.3 Cancer/Oncology
- 5.4.4 Cardiology
- 5.4.5 Other Applications
- 5.5 By End-User
- 5.5.1 Diagnostic Laboratories
- 5.5.2 Hospitals and Clinics
- 5.5.3 Other End-users
- 5.1 By Test Type
- 6. COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Abbott Laboratories
- 6.1.2 Becton, Dickinson and Company
- 6.1.3 Bio-Rad Laboratories, Inc.
- 6.1.4 Danaher Corporation
- 6.1.5 Diasorin
- 6.1.6 F. Hoffmann-La Roche Ltd
- 6.1.7 Nihon Kohden Corporation
- 6.1.8 Qiagen N.V
- 6.1.9 Siemens Healthineers
- 6.1.10 Thermo Fischer Scientific
- *List Not Exhaustive
- 6.1 Company Profiles
- 7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments